A Multicenter Study of the Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSVdeltaG-ZEBOV GP) for Pre-Exposure Prophylaxis in Individuals at Potential Occupational Risk for Ebola Virus Exposure (PREPARE)
Latest Information Update: 27 Jun 2025
At a glance
- Drugs RVSV-S-GP/VP40 vaccine (Primary)
- Indications Ebola virus infections
- Focus Pharmacodynamics
- Acronyms PREPARE
Most Recent Events
- 24 Jun 2025 Status changed from recruiting to completed.
- 15 Jan 2025 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.
- 15 Jan 2025 Planned primary completion date changed from 31 Dec 2024 to 31 Dec 2025.